Underneath the impressive market rally is a trend that doesn't seem quite right, according to J.P. Morgan.Marketsread more
Tesla is working on new battery cell designs, and a way to make their own cells, with R&D teams in a lab near its car plant in Fremont, California.Technologyread more
The Federal Reserve and the market are miles apart on interest rate expectations, and the disparity could cost the stock market a 7%-10% drop, economists say.Economyread more
Something unusual is happening in financial markets and it could mean more gains lie ahead for stocks, if history is any indication.Marketsread more
JP Morgan's Jamie Dimon says student lending "is a disgrace and it's hurting America."Economyread more
Online home goods retailer Wayfair sold roughly 1,600 mattresses and 100 bunk beds to Baptist Child and Family Services, a nonprofit that works as a federal contractor...Retailread more
The Senate will try to reconcile its emergency border aid plan with one passed by Nancy Pelosi and House Democrats.Politicsread more
During the foreclosure crisis, investors transformed the single-family home rental market into a formally managed asset class. Now they want new homes.Real Estateread more
Bitcoin topped the $13,000 level Wednesday, rallying to its highest price since January 2018.Bitcoinread more
Lenders including J.P. Morgan Chase and Bank of America are widely expected to increase dividends this week.Financeread more
The president raised $6 million alone at a fundraiser he attended at the Trump International Hotel on Tuesday in Washington.Politicsread more
The acquisition, first reported earlier in the day, would combine two of the largest U.S. drugstore chains. The price represents a 48 percent premium to Rite Aid's closing price on Monday.
The deal's total enterprise value is $17.2 billion, including acquired net debt. The companies expect it to close by the second half of next year.
"This combination will generate a stronger base for sustainable growth and investment into Rite Aid stores, while realizing synergies over time," said Walgreens Boots Alliance CEO Stefano Pessina in a statement.
Many companies in the industry have looked to cut costs in recent years amid changes like the Affordable Care Act.
Walgreens said it expects synergies of more than $1 billion from the deal. Rite Aid stores will initially operate under the same name as a wholly owned subsidiary.
Walgreens had net sales of $76.4 billion in fiscal 2014, accounting for about 20 percent of the retail prescription drug market. Rite Aid had prescription drug sales of $18.1 billion in fiscal 2015, up from $17.2 billion in the previous year.
Rite Aid shares closed more than 40 percent higher Tuesday after reports that a deal could be imminent. Before the spike, Rite Aid had a market capitalization of about $6.4 billion.
Walgreens and CVS shares also climbed Tuesday.